686 related articles for article (PubMed ID: 26920799)
1. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
2. Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
Subhedar DD; Shaikh MH; Shingate BB; Nawale L; Sarkar D; Khedkar VM; Kalam Khan FA; Sangshetti JN
Eur J Med Chem; 2017 Jan; 125():385-399. PubMed ID: 27688192
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
5. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Subhedar DD; Shaikh MH; Arkile MA; Yeware A; Sarkar D; Shingate BB
Bioorg Med Chem Lett; 2016 Apr; 26(7):1704-8. PubMed ID: 26927426
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
[TBL] [Abstract][Full Text] [Related]
11. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
[TBL] [Abstract][Full Text] [Related]
13. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
14. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
15. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
Saharan VD; Mahajan SS
Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
18. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
Shaikh MH; Subhedar DD; Arkile M; Khedkar VM; Jadhav N; Sarkar D; Shingate BB
Bioorg Med Chem Lett; 2016 Jan; 26(2):561-569. PubMed ID: 26642768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
